Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-09-16

Clinical Trial Update: The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis [NA]

View source ↗

Summary

The clinical trial evaluating polyunsaturated fatty acids for atopic dermatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyunsaturated fatty acids (PUFA) supplement (polyunsaturated fatty acids)

Snippet

Sponsor: Mead Johnson Nutrition | Conditions: Atopic Dermatitis | NA | Status: WITHDRAWN